FDA Adverse Event Injury Summary report: N

PRECISION®

MDR report key: 2822819 · Received November 7, 2012

Report

Report Number
3006630150-2012-02042
Event Type
Injury
Date Received
November 7, 2012
Date of Event
October 15, 2012
Report Date
October 15, 2012
Manufacturer
BOSTON SCIENTIFIC NEUROMODULATION
Product Code
LGW
PMA / PMN Number
030017
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

DEVICE EVALUATION INDICATED THAT THE IPG PASSED VISUAL TESTS PERFORMED. THE IPG WAS EXPLANTED DUE TO SURGICAL PAIN UNRELATED TO THE DEVICE. EXCESSIVE BATTERY DEPLETION WAS NOTED AFTER THE EXPLANT PROCEDURE. THE DEVICE EXHIBITED ANALOG INTEGRATED CIRCUIT (AIC) DAMAGE. THE MONOPOLAR ELECTROCAUTERY PROCEDURES ARE A KNOWN SOURCE OF HIGH-VOLTAGE TRANSIENT SIGNAL THAT CAN DAMAGE THE AIC. (B)(4). IT WAS REPORTED THAT ELECTROCAUTERY WAS USED DURING THE EXPLANT PROCEDURE. THE PADDLE LEAD WAS CUT. THIS KIND OF DAMAGE IS A RESULT OF A TYPICAL EXPLANT PROCEDURE AND IT IS NOT CONSIDERED A FAILURE.

Additional Manufacturer Narrative · 1

ADDITIONAL SUSPECT MEDICAL DEVICE COMPONENTS INVOLVED IN THE EVENT: MODEL: SC-8216-50, SERIAL: (B)(4), LEAD, 50CM DESCRIPTION: 434976.

Description of Event or Problem · 1

A REPORT WAS RECEIVED THAT THE PATIENT HAD PAIN AT THE LEAD AND POCKET SITES. THE PHYSICIAN BELIEVES THE PATIENT'S SYMPTOMS WERE PROCEDURE RELATED AND CAUSED HER FIBROMYALGIA TO FLARE UP. THE PATIENT WAS EXPLANTED AND IS REPORTEDLY DOING WELL FOLLOWING THE PROCEDURE.

Description of Event or Problem · 1

A REPORT WAS RECEIVED THAT THE PATIENT HAD PAIN AT THE LEAD AND POCKET SITES. THE PHYSICIAN BELIEVES THE PATIENT'S SYMPTOMS WERE PROCEDURE RELATED AND CAUSED HER FIBROMYALGIA TO FLARE UP. THE PATIENT WAS EXPLANTED AND IS REPORTEDLY DOING WELL FOLLOWING THE PROCEDURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 PRECISION® SPINAL CORD STIMULATOR LGW BOSTON SCIENTIFIC NEUROMODULATION SC-1110-02 N/A

Patients

Seq Age Sex Outcome Treatment
1 69 YR Required Intervention